Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2003

01-05-2003 | Concise Article

Peripartum Tuberculosis as a Form of Immunorestitution Disease

Authors: V. C. C. Cheng, P. C. Y. Woo, S. K. P. Lau, C. H. Y. Cheung, R. W. H. Yung, L. Y. C. Yam, K. Y. Yuen

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2003

Login to get access

Abstract

The aim of this study was to assess the clinical spectrum of peripartum tuberculosis from the perspective of immunorestitution disease. Of 29 patients with peripartum tuberculosis, 27 (93.1%) had extrapulmonary tuberculosis, 20 (69%) of whom were affected in the central nervous system. Twenty-two (75.9%) patients had no clinical features suggestive of tuberculosis during pregnancy. The median time from delivery to the onset of immunorestitution was 4 days, but treatment with anti-tuberculous therapy was delayed for a median time of 27 days after the onset of symptoms. Despite therapy, 11 (38%) patients died and 4 (13.8%) had residual functional deficits. Peripartum tuberculosis is an important differential diagnosis of postpartum fever (of unknown origin) without localized signs.
Literature
2.
go back to reference Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR (2001) Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 120:193–197PubMed Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR (2001) Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 120:193–197PubMed
3.
go back to reference Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY (2002) Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21:803–809CrossRefPubMed Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY (2002) Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21:803–809CrossRefPubMed
4.
go back to reference Covelli HD, Wilson RT (1978) Immunologic and medical considerations in tuberculin-sensitized pregnant patients. Am J Obstet Gynecol 132:256–259PubMed Covelli HD, Wilson RT (1978) Immunologic and medical considerations in tuberculin-sensitized pregnant patients. Am J Obstet Gynecol 132:256–259PubMed
5.
go back to reference Stephanopoulos C (1956) The development of tuberculosus meningitis during pregnancy. Amer Rev Tuberculosis 76:1079–1087 Stephanopoulos C (1956) The development of tuberculosus meningitis during pregnancy. Amer Rev Tuberculosis 76:1079–1087
6.
go back to reference D'Cruz IA, Dandekar AC (1968) Tuberculous meningitis in pregnant and puerperal women. Obstet Gynecol 31:775–778PubMed D'Cruz IA, Dandekar AC (1968) Tuberculous meningitis in pregnant and puerperal women. Obstet Gynecol 31:775–778PubMed
7.
go back to reference Maheswaran C, Neuwirth RS (1973) An unusual case of postpartum fever. Acute hematogenous tuberculosis. Obstet Gynecol 41:765–769PubMed Maheswaran C, Neuwirth RS (1973) An unusual case of postpartum fever. Acute hematogenous tuberculosis. Obstet Gynecol 41:765–769PubMed
8.
go back to reference Brandstetter RD, Murray HW, Mellow E (1980) Tuberculous meningitis in a puerperal woman. JAMA 244:2440CrossRefPubMed Brandstetter RD, Murray HW, Mellow E (1980) Tuberculous meningitis in a puerperal woman. JAMA 244:2440CrossRefPubMed
9.
go back to reference Myers JP, Perlstein PH, Light IJ, Towbin RB, Dincsoy HP, Dincsoy MY (1981) Tuberculosis in pregnancy with fatal congenital infection. Pediatrics 67:89–94PubMed Myers JP, Perlstein PH, Light IJ, Towbin RB, Dincsoy HP, Dincsoy MY (1981) Tuberculosis in pregnancy with fatal congenital infection. Pediatrics 67:89–94PubMed
10.
go back to reference Good JT Jr, Iseman MD, Davidson PT, Lakshminarayan S, Sahn SA (1981) Tuberculosis in association with pregnancy. Am J Obstet Gynecol 140:492–498PubMed Good JT Jr, Iseman MD, Davidson PT, Lakshminarayan S, Sahn SA (1981) Tuberculosis in association with pregnancy. Am J Obstet Gynecol 140:492–498PubMed
11.
go back to reference Brar HS, Golde SH, Egan JE (1987) Tuberculosis presenting as puerperal fever. Obstet Gynecol 70(3 Pt 2):488–490PubMed Brar HS, Golde SH, Egan JE (1987) Tuberculosis presenting as puerperal fever. Obstet Gynecol 70(3 Pt 2):488–490PubMed
12.
go back to reference Nsofor BI, Trivedi ON (1988) Postpartum paraplegia due to spinal tuberculosis. Trop Doct 18:52–53PubMed Nsofor BI, Trivedi ON (1988) Postpartum paraplegia due to spinal tuberculosis. Trop Doct 18:52–53PubMed
13.
go back to reference Kingdom JC, Kennedy DH (1989) Tuberculous meningitis in pregnancy. Br J Obstet Gynaecol 96:233–235PubMed Kingdom JC, Kennedy DH (1989) Tuberculous meningitis in pregnancy. Br J Obstet Gynaecol 96:233–235PubMed
14.
go back to reference Kuppuswami N, Powell L, Freese U (1995) Extrapulmonary tuberculosis as a cause of unexplained postpartum fever. A case report. J Reprod Med 40:232–234PubMed Kuppuswami N, Powell L, Freese U (1995) Extrapulmonary tuberculosis as a cause of unexplained postpartum fever. A case report. J Reprod Med 40:232–234PubMed
15.
go back to reference Sacks G, Sargent I, Redman C (1999) Innate immunity in pregnancy. Immunol Today 20:114–118PubMed Sacks G, Sargent I, Redman C (1999) Innate immunity in pregnancy. Immunol Today 20:114–118PubMed
16.
go back to reference Carter EJ, Mates S (1994) Tuberculosis during pregnancy. The Rhode Island experience, 1987 to 1991. Chest 106:1466–1470PubMed Carter EJ, Mates S (1994) Tuberculosis during pregnancy. The Rhode Island experience, 1987 to 1991. Chest 106:1466–1470PubMed
17.
go back to reference Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM (2000) Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30:882–892PubMed Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM (2000) Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30:882–892PubMed
Metadata
Title
Peripartum Tuberculosis as a Form of Immunorestitution Disease
Authors
V. C. C. Cheng
P. C. Y. Woo
S. K. P. Lau
C. H. Y. Cheung
R. W. H. Yung
L. Y. C. Yam
K. Y. Yuen
Publication date
01-05-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-0927-1

Other articles of this Issue 5/2003

European Journal of Clinical Microbiology & Infectious Diseases 5/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.